-
1دورية أكاديمية
المؤلفون: Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
المصدر: Therapeutic Advances in Gastroenterology, Vol 14 (2021)
مصطلحات موضوعية: Diseases of the digestive system. Gastroenterology, RC799-869
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1756-2848
-
2دورية أكاديمية
المؤلفون: Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
المصدر: Therapeutic Advances in Gastroenterology, Vol 13 (2020)
مصطلحات موضوعية: Diseases of the digestive system. Gastroenterology, RC799-869
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1756-2848
-
3
المؤلفون: Marjolein J.E. Greuter, Felice N. van Erning, Cornelis J A Punt, Gabrielle Jongeneel, Geraldine R. Vink, Jos W. R. Twisk, Veerle M.H. Coupé, Miriam Koopman
المساهمون: Epidemiology and Data Science, APH - Health Behaviors & Chronic Diseases, APH - Methodology, Orthopedic Surgery and Sports Medicine, CCA - Cancer Treatment and quality of life, CCA - Cancer Treatment and Quality of Life
المصدر: International Journal of Cancer
International Journal of Cancer, 148(11), 2702-2711. Wiley-Liss Inc.
International journal of cancer. Journal international du cancer, 148(11), 2702-2711. Wiley-Liss Inc.
Jongeneel, G, Greuter, M J E, van Erning, F N, Twisk, J W R, Koopman, M, Punt, C J A, Vink, G R & Coupé, V M H 2021, ' Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients : A prospective cohort study ', International Journal of Cancer, vol. 148, no. 11, pp. 2702-2711 . https://doi.org/10.1002/ijc.33472مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, longitudinal data, Colorectal cancer, Clinical Decision-Making, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Internal medicine, medicine, Humans, Clinical significance, Longitudinal Studies, Prospective Studies, Prospective cohort study, Aged, Neoplasm Staging, business.industry, Peripheral Nervous System Diseases, Middle Aged, medicine.disease, Oxaliplatin, adjuvant chemotherapy, Peripheral neuropathy, Treatment Outcome, Oncology, colon cancer, quality of life, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Cohort, Female, business, Colorectal Neoplasms, Cancer Epidemiology, medicine.drug
-
4دورية أكاديمية
المؤلفون: Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. Erning, Miriam Koopman, Jan P. Medema, Raju Kandimalla, Ajay Goel, Luis Bujanda, Gerrit A. Meijer, Remond J. A. Fijneman, Martijn G. H
المصدر: Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), The European Journal of Health Economics. 21(7):1059-1073
-
5
المؤلفون: Geraldine R. Vink, Miriam Koopman, Marjolein J.E. Greuter, Cornelis J A Punt, Jan Paul Medema, Gabrielle Jongeneel, Louis Vermeulen, Veerle M.H. Coupé, Jan N. M. IJzermans, Felice N. van Erning, Natalia Kunst
المساهمون: Center of Experimental and Molecular Medicine, Radiotherapy, Oncology, Amsterdam Gastroenterology Endocrinology Metabolism, CCA - Cancer Treatment and Quality of Life, Epidemiology and Data Science, Orthopedic Surgery and Sports Medicine, APH - Methodology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Surgery
المصدر: Jongeneel, G, Greuter, M J E, Kunst, N, Van Erning, F N, Koopman, M, Medema, J P, Vermeulen, L, Ijzermans, J N M, Vink, G R, Punt, C J A & Coupé, V M H 2021, ' Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer : The potential value of prognostic molecular markers ', Cancer Epidemiology Biomarkers and Prevention, vol. 30, no. 9, pp. 1726-1734 . https://doi.org/10.1158/1055-9965.EPI-21-0078
Cancer Epidemiology Biomarkers and Prevention, 30(9), 1726-1734. American Association for Cancer Research Inc.
Cancer Epidemiol Biomarkers Prev
Cancer Epidemiology Biomarkers and Prevention, 30(9), 1726-1734مصطلحات موضوعية: Oncology, medicine.medical_specialty, Epidemiology, Colorectal cancer, Cost-Benefit Analysis, MEDLINE, Risk Assessment, Article, Value of information, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Selection (genetic algorithm), Neoplasm Staging, Netherlands, business.industry, Cohort model, Cost-effectiveness analysis, Guideline, medicine.disease, Markov Chains, Chemotherapy, Adjuvant, Mutation (genetic algorithm), Colonic Neoplasms, Quality-Adjusted Life Years, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291430f09591738742cfd1e86e2bf290
https://research.vumc.nl/en/publications/8c94bda8-4830-4cfa-9a9f-b62f11a0b4a6 -
6
المؤلفون: Miriam Koopman, Marjolein J.E. Greuter, Gabrielle Jongeneel, Veerle M.H. Coupé, Felice N. van Erning, Geraldine R. Vink, Cornelis J A Punt
المساهمون: Oncology, CCA - Cancer Treatment and Quality of Life, Epidemiology and Data Science, Orthopedic Surgery and Sports Medicine, APH - Methodology, CCA - Cancer Treatment and quality of life
المصدر: Therapeutic advances in gastroenterology, 14. SAGE Publications Ltd
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, 14. SAGE Publications Ltd
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Jongeneel, G, Greuter, M J E, van Erning, F N, Koopman, M, Vink, G R, Punt, C J A & Coupé, V M H 2021, ' Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients ', Therapeutic Advances in Gastroenterology, vol. 14 . https://doi.org/10.1177/1756284821995715مصطلحات موضوعية: Oncology, stage II, medicine.medical_specialty, Adjuvant chemotherapy, Colorectal cancer, Cost effectiveness, medicine.medical_treatment, Stage ii, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, lcsh:RC799-869, cost-effectiveness, Selection (genetic algorithm), Original Research, business.industry, 030503 health policy & services, Gastroenterology, biomarkers, personalized medicine, medicine.disease, adjuvant chemotherapy, colon cancer, 030220 oncology & carcinogenesis, lcsh:Diseases of the digestive system. Gastroenterology, Personalized medicine, 0305 other medical science, business, Adjuvant, Stage ii colon cancer
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::916aa8c1b6554a4fcf85b861f94c8e4a
https://pure.amc.nl/en/publications/modelbased-effectiveness-and-costeffectiveness-of-riskbased-selection-strategies-for-adjuvant-chemotherapy-in-dutch-stage-ii-colon-cancer-patients(9424a82c-83da-4a85-9e43-e4ad6db7b6e0).html -
7
المؤلفون: Geraldine R. Vink, Cornelis J. A. Punt, Marjolein J.E. Greuter, Gabrielle Jongeneel, Veerle M.H. Coupé, Felice N. van Erning, Miriam Koopman
المساهمون: Oncology, CCA - Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Epidemiology and Data Science, APH - Personalized Medicine, Orthopedic Surgery and Sports Medicine, Internal medicine, APH - Methodology, CCA - Cancer Treatment and quality of life, APH - Quality of Care
المصدر: Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Jongeneel, G, Greuter, M J E, van Erning, F N, Koopman, M, Vink, G R, Punt, C J A & Coupé, V M H 2020, ' Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients ', Therapeutic Advances in Gastroenterology, vol. 13 . https://doi.org/10.1177/1756284820954114
Therapeutic advances in gastroenterology, 13. SAGE Publications Ltd
Therapeutic Advances in Gastroenterology, 13. SAGE Publications Ltd
Therapeutic Advances in Gastroenterologyمصطلحات موضوعية: Oncology, medicine.medical_specialty, treatment duration, cost effectiveness, business.industry, Adjuvant chemotherapy, Cost effectiveness, Colorectal cancer, Treatment duration, Gastroenterology, medicine.disease, adjuvant chemotherapy, 03 medical and health sciences, 0302 clinical medicine, colon cancer, 030220 oncology & carcinogenesis, Internal medicine, Medicine, lcsh:Diseases of the digestive system. Gastroenterology, 030212 general & internal medicine, lcsh:RC799-869, business, Stage ii colon cancer, Original Research
-
8
المؤلفون: Jan N. M. IJzermans, Jan Paul Medema, Cornelis J. A. Punt, Marjolein J.E. Greuter, Felice N. van Erning, Martijn G.H. van Oijen, Geraldine R. Vink, Gabrielle Jongeneel, Raju Kandimalla, Gerrit A. Meijer, Ajay Goel, Miriam Koopman, Veerle M.H. Coupé, Luis Bujanda, Remond J.A. Fijneman
المساهمون: Epidemiology and Data Science, APH - Personalized Medicine, Pathology, Internal medicine, Orthopedic Surgery and Sports Medicine, APH - Methodology, CCA - Cancer Treatment and quality of life, Center of Experimental and Molecular Medicine, Radiotherapy, CCA - Imaging and biomarkers, Oncology, APH - Quality of Care, CCA - Cancer Treatment and Quality of Life, Surgery
المصدر: European Journal of Health Economics, 21(7), 1059-1073. Springer Verlag
The European Journal of Health Economics
European journal of health economics : HEPAC, 21(7), 1059-1073. Springer Verlag
Addi. Archivo Digital para la Docencia y la Investigación
instname
The European Journal Of Health Economics, 21(7), 1059-1073. Springer-Verlag
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
Jongeneel, G, Greuter, M J E, van Erning, F N, Koopman, M, Medema, J P, Kandimalla, R, Goel, A, Bujanda, L, Meijer, G A, Fijneman, R J A, van Oijen, M G H, Ijzermans, J, Punt, C J A, Vink, G R & Coupé, V M H 2020, ' Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) ', European Journal of Health Economics, vol. 21, no. 7, pp. 1059-1073 . https://doi.org/10.1007/s10198-020-01199-4مصطلحات موضوعية: Oncology, Male, Colorectal cancer, Cost-Benefit Analysis, Economics, Econometrics and Finance (miscellaneous), chemotherapy, survival analysis, fluorouracil, 0302 clinical medicine, Medicine, 030212 general & internal medicine, risk-factors, Netherlands, Aged, 80 and over, Health Care Rationing, Health Policy, Cohort model, Age Factors, Middle Aged, I19, Markov Chains, adjuvant chemotherapy, colon cancer, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Cohort, Colonic Neoplasms, Practice Guidelines as Topic, Biomarker (medicine), Female, Quality-Adjusted Life Years, medicine.medical_specialty, Disease-Free Survival, External validity, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Biomarkers, Tumor, Humans, mismatch repair status, Survival analysis, Aged, Neoplasm Staging, clinical-trials, Original Paper, therapy, business.industry, Markov cohort model, colorectal-cancer, Reproducibility of Results, Guideline, medicine.disease, mortality, Cancer registry, D61, Neoplasm Recurrence, Local, business, braf
وصف الملف: application/pdf
-
9
المؤلفون: Felice N. van Erning, Miriam Koopman, Cornelis J. A. Punt, Marjolein J.E. Greuter, Gabrielle Jongeneel, Geraldine R. Vink, Thomas Klausch, Veerle M.H. Coupé
المساهمون: Epidemiology and Data Science, APH - Methodology, CCA - Cancer Treatment and quality of life, AGEM - Re-generation and cancer of the digestive system, APH - Quality of Care, Oncology, CCA - Cancer Treatment and Quality of Life
المصدر: Jongeneel, G, Klausch, T, van Erning, F N, Vink, G R, Koopman, M, Punt, C J A, Greuter, M J E & Coupé, V M H 2020, ' Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data ', International Journal of Cancer, vol. 146, no. 11, pp. 2968-2978 . https://doi.org/10.1002/ijc.32629
International Journal of Cancer
International Journal of Cancer, 146(11), 2968-2978. Wiley-Liss Inc.
International journal of cancer. Journal international du cancer, 146(11), 2968-2978. Wiley-Liss Inc.مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, treatment effect, Organoplatinum Compounds, Colorectal cancer, Leucovorin, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, FOLFOX, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Neoplasm Staging, Netherlands, Randomized Controlled Trials as Topic, real-world data, business.industry, Proportional hazards model, Hazard ratio, real‐world data, medicine.disease, randomized clinical trial, Cancer registry, adjuvant chemotherapy, colon cancer, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Colonic Neoplasms, Propensity score matching, Female, Observational study, Fluorouracil, business, Cancer Epidemiology, medicine.drug
-
10
المؤلفون: Johanna M. van Dongen, Johannes Brug, Mai J. M. Chinapaw, Saskia Persoon, Laurien M. Buffart, Judith E. Bosmans, Gabrielle Jongeneel, Marie José Kersten, Frans Nollet
المساهمون: VU University medical center, Public and occupational health, Rehabilitation medicine, Epidemiology and Data Science, APH - Health Behaviors & Chronic Diseases, CCA - Cancer Treatment and quality of life, APH - Societal Participation & Health, Graduate School, CCA - Cancer Treatment and Quality of Life, Clinical Haematology, AMS - Restoration & Development, Health Economics and Health Technology Assessment, APH - Mental Health, APH - Methodology, AMS - Ageing and Morbidity
المصدر: van Dongen, J M, Persoon, S, Jongeneel, G, Bosmans, J E, Kersten, M J, Brug, J, Nollet, F, Chinapaw, M J M & Buffart, L M 2019, ' Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation : results from the EXIST study ', Journal of Cancer Survivorship, vol. 13, no. 4, pp. 558-569 . https://doi.org/10.1007/s11764-019-00775-9
van Dongen, J M, Persoon, S, Jongeneel, G, Bosmans, J E, Kersten, M J, Brug, J, Nollet, F, Chinapaw, M J M & Buffart, L M 2019, ' Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation : results from the EXIST study ', Journal of cancer survivorship, vol. 13, no. 4, pp. 558-569 . https://doi.org/10.1007/s11764-019-00775-9
Journal of Cancer Survivorship
Journal of Cancer Survivorship, 13(4), 558-569. Springer New York
Journal of cancer survivorship, 13(4), 558-569. Springer New Yorkمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lymphoma, Cost effectiveness, Cost-Benefit Analysis, Physical fitness, Transplantation, Autologous, Article, Long-term effectiveness, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Quality of life, Cancer Survivors, SDG 3 - Good Health and Well-being, Multiple myeloma, Intervention (counseling), Surveys and Questionnaires, medicine, Exercise intervention, Humans, 030212 general & internal medicine, Fatigue, Netherlands, Hand Strength, Oncology (nursing), business.industry, Hematopoietic Stem Cell Transplantation, Cardiorespiratory fitness, Middle Aged, Missing data, Exercise Therapy, Treatment Outcome, Oncology, Cardiorespiratory Fitness, Physical Fitness, 030220 oncology & carcinogenesis, Hematologic Neoplasms, Economic evaluation, Physical therapy, Quality of Life, Cost-effectiveness, Female, Quality-Adjusted Life Years, business, Follow-Up Studies